Investors

Financials & Filings

Document Details

Form
S-8 POS
Filing Date
Jun 3, 2026
Document Date
Jun 3, 2026
Form Description
Post-effective amendment to an S-8 filing
Filing Group
Registration Statements
Company
Xenon Pharmaceuticals Inc.
Issuer
Xenon Pharmaceuticals Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Investor inquiries

Tucker Kelly 
Chief Financial Officer
investors@xenon-pharma.com
 

Request Information

Email alerts

Sign up here to receive email alerts from Xenon Pharmaceuticals

Sign Up